Back

Angiotensin receptor-neprilysin inhibition in patients with end-stage kidney disease and refractory hypertension

30 August 2024 (12:00 - 12:12)
Organised by: Logo
Congress Presentation Part of: Challenges with cardiovascular comorbidities Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Chin-Chou HUANG

National Yang Ming Chiao Tung University, Taipei (Taiwan)

4 More presentations in this session

Presentation thumbnail
At the intersection of ischemic and bleeding risk – What type-2 myocardial infarction unveils in young patient with HIV infection and uterine fibroma
Doctor M. Iurascu-Botezatu (Bucharest, RO)
Slides Video
Presentation thumbnail
Thrombotic odyssey: navigating the challenges in a complex medical case
Doctor A. Stoica (Bucharest, RO)
Slides Video
Presentation thumbnail
Peritoneal dialysis: is it time to move to DOACs?
Mrs S. Burja Piko (Maribor, SI)
Slides Video
Presentation thumbnail
Systemic sclerosis/ polymyositis (SSC/ PM) overlap syndrome induced cardiomyopathy in the context of renal crisis- a diagnostic dilemma
Doctor A. Karthik (Preston, GB)
Slides Video

Access the full session

Session thumbnail
Challenges with cardiovascular comorbidities
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy
thumbnail
Congress Presentation
Left adrenal adenoma diagnosed without confirmation test but via adrenal vein sampling and treated with super-selective adrenal arterial embolization: facing the complexity of real world
thumbnail
Congress Presentation
Refractory arterial hypertension - but what if there is more to it?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources